Medical Diagnositic

Lepu Biopharma grants ArriVent exclusive license for MRG007 ADC

Promising treatment for gastrointestinal cancers aims to set new standards in precision oncology....

MediBeacon® Transdermal GFR System Secures FDA Approval

Innovative device offers non-invasive kidney function assessment for improved patient care....

Digbi Health Expands Multi-Condition Platform to Boost GLP-1 Drug Effectiveness

Digbi Care™ integrates glucose monitoring, microbiome, and genetics for personalized obesity management....

Illuccix® Secures European Approval

Breakthrough imaging agent advances prostate cancer diagnostics across Europe....

UCSF and GE HealthCare Launch Care Innovation Hub to Tackle Cancer and Neurodegenerative Diseases with Advanced Imaging Solutions

New joint research initiative combines UCSF’s clinical and research expertise with GE HealthCare’s engineering innovation to improve diagnosis, enhance access to precision treatments, and drive breakthroughs in brain health, oncology, and imaging technology....

Viz.ai partners with Guardant Health to enhance Lung Cancer detection and treatment

Proposed collaboration aims to integrate cutting-edge AI and genomic insights to advance guideline-directed medical therapy...

Erba Transasia group introduces its’ advanced haematology analyzer in Kerala

Clinical Symposium held on “Deeper Insights in Haematology”; Erba H7100 aids early/accurate diagnosis of cancer & other blood disorders, a growing concern for Kerala...

DFE Pharma expands its C2F Center of Excellence to advance the development of critical respiratory treatments.

This expansion enables DFE Pharma to offer specialized analytical services for Dry Powder Inhalation (DPI) dosage forms....